Jinhai Medical Technology Limited (HKG:2225)

Jinhai Medical Technology Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	18.23	35.59	10.45	20.2	15.39	16.26
Short-Term Investments	15.79	2.1	2.33	3.34	3.08	0.92
Trading Asset Securities	0.54	1.19	4.48	6.56	7.59	8.74
Cash & Short-Term Investments	34.56	38.88	17.26	30.1	26.06	25.91
Cash Growth	395.78%	125.30%	-42.66%	15.51%	0.55%	-0.16%
Accounts Receivable	25.93	15.38	4.86	5.53	2.21	1.46
Other Receivables	1.58	1.59	1.63	1.96	1.3	0.94
Receivables	27.62	17.08	6.6	7.61	3.51	2.44
Inventory	3.29	3	2.77	2.1	0.96	0.87
Prepaid Expenses	1.94	-	-	-	-	0.15
Other Current Assets	6.8	5.47	3.54	2.88	2.78	1.34
Total Current Assets	74.2	64.43	30.16	42.68	33.3	30.71
Property, Plant & Equipment	6.83	4.58	6.3	6.43	5.73	1.83
Long-Term Investments	0.56	0.54	0.56	0.56	-	-
Goodwill	0.52	0.52	0.52	-	-	-
Long-Term Deferred Tax Assets	0.01	0.01	0.02	0.04	0.16	0.19
Other Long-Term Assets	18.23	18.75	21.31	12.51	1.08	1.01
Total Assets	100.35	88.83	58.87	62.22	40.27	33.77

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	23.36	16.4	5.13	5.46	0.48	0.26
Accrued Expenses	-	2.65	3.54	4.57	4.52	4.53
Short-Term Debt	11.89	11.97	10.8	4.72	0.97	-
Current Portion of Leases	0.91	1.08	0.99	1.89	1.8	1.61
Current Income Taxes Payable	-	-	-	0.89	0.7	0.43
Current Unearned Revenue	1.1	0.61	1.36	0.53	2.09	1.2
Other Current Liabilities	5.96	2.3	1.54	3.19	3.45	1.43
Total Current Liabilities	43.21	35.02	23.36	21.25	14	9.47
Long-Term Debt	-	-	-	-	0.97	-
Long-Term Leases	1.42	1.86	2.73	3.48	0.71	0.25
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.03
Total Liabilities	44.63	36.87	26.09	24.73	15.68	9.75

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2.31	2.3	2.25	2.25	2.14	2.14
Additional Paid-In Capital	-	58.78	32.32	32.32	14.96	14.96
Retained Earnings	-	-31.97	-16.29	1.68	6.12	5.65
Comprehensive Income & Other	49.66	22.17	13.52	1.23	1.15	1.52
Total Common Equity	51.97	51.29	31.81	37.47	24.37	24.28
Minority Interest	3.75	0.67	0.97	0.02	0.22	-0.25
Shareholders' Equity	55.72	51.96	32.78	37.49	24.59	24.02
Total Liabilities & Equity	100.35	88.83	58.87	62.22	40.27	33.77

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	14.21	14.91	14.52	10.08	4.45	1.87
Net Cash (Debt)	20.34	23.97	2.73	20.01	21.61	24.04
Net Cash Growth	-	776.99%	-86.34%	-7.37%	-10.14%	17.57%
Net Cash Per Share	0.00	0.00	0.00	0.00	0.00	0.00
Filing Date Shares Outstanding	5,299	5,290	5,170	5,170	4,920	4,920
Total Common Shares Outstanding	5,299	5,290	5,170	5,170	4,920	4,920
Working Capital	30.99	29.42	6.81	21.43	19.3	21.24
Book Value Per Share	0.01	0.01	0.01	0.01	0.00	0.00
Tangible Book Value	51.44	50.77	31.28	37.47	24.37	24.28
Tangible Book Value Per Share	0.01	0.01	0.01	0.01	0.00	0.00
Buildings	-	4.16	4.17	4.17	4.17	4.17
Machinery	-	3.26	3.4	1.83	4.6	2.08
Construction In Progress	-	-	-	1.64	0.99	0.25
Leasehold Improvements	-	2.96	2.99	1.93	1.96	1.7

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 14, 2026

Data Sources Report a data error